Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Ask the Doctor Boosts Crypto Utility With Jump Onto Shiba Inu Bandwagon

By Will Ashworth, InvestorPlace Contributor

Ask the Doctor added Shiba Inu to its balance sheet to become the latest company to accept the token. That could be good for SHIB-USD price. 

7 Boating Stocks to Buy as GM Takes the EV War to the Water

By Will Ashworth, InvestorPlace Contributor

Although boating stocks have cooled off in 2021, the transition to electric promises to keep sales rising for years to come.

Does the Crypto.com Coin Meet the Utility Sniff Test?

By Will Ashworth, InvestorPlace Contributor

A big criterion for investing in cryptocurrencies remains utility. Does the Crypto.com Coin meet the utility sniff test? I’ll have a look.   

Deathstar Logo Now Seems Apt as AT&T Is the Ultimate Value Destructor

By Will Ashworth, InvestorPlace Contributor

AT&T is one of the biggest value destroyers in American business. If you’re thinking about buying T stock, prepare to be disappointed.   

If November Is Any Indication, Clover Health Is on Life Support

By Will Ashworth, InvestorPlace Contributor

November was brutal for shareholders of Clover Health. CLOV stock lost close to 40% of its value. Trading under $5, it’s tough to recommend. 

Load More